News

Tris Pharma has formed the organization along with a licensing agreement with Braingaze for development, distribution of the technology.

Compared with divided dosing, patients with once-daily dosing had shorter illness duration and better clinical outcomes.

Let us know if we'll see you there!

Wine for mental health…?

Study results suggest the potential for a scalable, single-dose treatment approach.

It's time for a psychological spring cleaning yet again...

What are the most effective approaches to SUD treatment in this unique patient population?

Explore the devastating impact of substance abuse, human trafficking, and conflict on individuals and communities.

Recent research investigated the benefits and risks of augmentation compared with switching strategies for TRD in older adults.

Trauma is the distance between the reach and the grasp for our chosen image.

Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints of a new phase 3 study.

Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.

Are you ready to discuss the Black youth crisis and the need for dynamic conversations?

Explore the connections between jazz and psychiatry.

How can consultation-liaison psychiatry help identify BPD and facilitate effective communication between patients and medical teams during these patients’ admissions?

How can telehealth aid in the treatment of opioid use disorders in this patient population?

Here’s why you should attend the Yale Child Study Center Black Youth Mental Health Case Conference.

Rosine Perelberg, PhD, discusses psychoanalytic thought, social anthropology, and the future of psychoanalysis.

Though compassion would seem to be part and parcel of psychiatry, its value and expression has seemed to vary.

From a look at record-high suicide rates to subspecialty shortages in psychiatry, here are highlights from the week in Psychiatric Times.

Researchers investigated the effects of this supplementation on cognitive function and disease severity in schizophrenia. Here’s what they found.

Learn more about the latest data on KarXT, which is posed to be the first new pharmacological treatment for schizophrenia.

What is new in research on schizophrenia?

Suicide is a word that conjures a wide range of intense emotions.

Poetry for peace in a time of war.

"I shall forget civilization, I shall forget color, caste, I shall move in a fantastic world of raceless men and women..."

How does everything connect?

A supplemental new drug application was submitted for the combination of brexpiprazole and sertraline in the treatment of PTSD in adults.

Take a look back at our recent coverage relating to our April content theme.